Drug intelligence / Profile preview

(C8-S)-hydantocidin 5'-phosphate

Development stage
Preclinical
Modality
Small Molecules
01

Overview

(C8-S)-hydantocidin 5'-phosphate is a synthetic small molecule and stereoisomer of hydantocidin 5'-phosphate. It is structurally related to natural nucleoside analogs and features a spirocyclic hydantoin core with phosphate substitution at the 5' position. This compound has been studied as an inhibitor of adenylosuccinate synthetase—an enzyme involved in the purine nucleotide biosynthesis pathway—by mimicking substrate or intermediate states within the enzyme's active site. Its primary use is as a biochemical tool or discovery agent for probing purine metabolism and potential antiparasitic activity against targets such as Plasmodium adenylosuccinate synthetase[4][8]. There are no approved medical indications.

Other names
(2S)-5-((5S,7R,8S,9R)-8,9-dihydroxy-2,4-dioxo-7-((phosphonooxy)methyl)-6-oxa-1,3-diazaspiro(4.4)nonan-3-yl)-2-(N-hydroxy-N-(hydroxymethyl)amino)pentanoic acid(2S)-5-[(5S,7R,8S,9R)-8,9-dihydroxy-2,4-dioxo-7-(phosphonooxy)methyl]-6‑oxa‑1,3‑diazaspiro[4.4]nonan‑3‑yl]-2-[N-hydroxy-N-(hydroxymethyl)amino]pentanoic acid
02

Targets

ADSS2 (Adenylosuccinate synthetase)

Beyond the preview

Go deeper on (C8-S)-hydantocidin 5'-phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (C8-S)-hydantocidin 5'-phosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call